Company profileNeural interface
FUTRUE Neurosciences
A German company developing a micro-ECoG array, with ambitions it has stated more fully than it has shown.
- Location
- Gräfelfing, Germany
- Class
- Neural interfaceNot counted among core BCI companies.
- Website
- futrue-neurosciences.com
- Sources last checked
- 4 Oct 2026
What they are building
Part of the FUTRUE group near Munich. It says it has developed a 512-electrode micro-ECoG array for recording and stimulation.
- Interface category
- Electrocorticography
- Signal
- Local field potentials, including high-gamma activity
- Invasiveness
- Invasive
- Recording / stimulation
- Recording and stimulation
- Main use cases
- Restore
Where they are clinically
Preclinical
Bench, animal or cadaver work. No human participants.
All available information is from the company. No animal or human data, research partners or registered studies have been published.
Access today
Concept
A proposed approach without published human or animal demonstration.
- Shown in people
- Nothing that can be verified: a press release describes a 512-electrode array.
- Still an aim
- First clinical applications, for which the company said it would lay the foundation during 2026.
- What stands in the way
- Outside evidence: no partner, study or paper is public.
On record here: 0 peer-reviewed papers
This technology remains experimental and is not an established treatment. Access is limited to registered clinical studies.
Why this company matters
FUTRUE Neurosciences belongs to a German healthcare group and is unusually direct about its aim to lead the field by 2030. What could be verified in October 2026 is a press release. We list it because a German entrant with industrial backing matters to the European picture, and we will move it up the stage ladder when a study, a partner or a paper appears.
Key milestones
31 Mar 2026
Company announces a 512-electrode micro-ECoG array and says it aims to lay the foundation for first clinical applications later in 2026.
Leadership
Clemens Fischer
Founder
As publicly stated by the organisation. Not a complete list.
Competitive context
ECoGFirst-in-human
CorTec
A fully implanted closed-loop system that both records from and stimulates the cortical surface.
ECoGFirst-in-human
INBRAIN Neuroelectronics
Graphene-based cortical interfaces for high-resolution recording and stimulation.
ECoGApproved / cleared
Precision Neuroscience
A thin-film cortical surface array that slides under the skull through a narrow slit.
Sources
- 01
FUTRUE Neurosciences Reaches Major Milestone (opens in a new tab)
Company reportedFUTRUE GmbH press release (news aktuell)31 Mar 2026Checked against source 4 Oct 2026
Press release. Names no research partners and reports no animal or human testing.